ReShape Lifesciences Inc.
RSLS
$0.6355
$0.00050.08%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Net Income | -1.58M | -1.60M | -2.19M | -1.70M | -3.53M |
Total Depreciation and Amortization | 5.00K | 6.00K | 6.00K | 7.00K | 50.00K |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 262.00K | -26.00K | -339.00K | -5.00K | 922.00K |
Change in Net Operating Assets | 1.00M | 258.00K | 454.00K | -761.00K | -218.00K |
Cash from Operations | -311.00K | -1.36M | -2.07M | -2.46M | -2.78M |
Capital Expenditure | -- | -- | -- | 0.00 | 0.00 |
Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00 | 0.00 |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | -- | -- | 0.00 | 0.00 |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | 0.00 | 24.00K | -- | 5.12M | 0.00 |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | 338.00K | -338.00K |
Cash from Financing | 0.00 | 24.00K | -- | 5.46M | -338.00K |
Foreign Exchange rate Adjustments | 1.00K | 7.00K | -8.00K | 6.00K | 0.00 |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -310.00K | -1.33M | -2.08M | 3.01M | -3.12M |